CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: